Accelerated Pharma Overview

  • Year Founded
  • 2014

Year Founded

  • Status
  • Private

  • Employees
  • 6

Employees

  • Latest Deal Type
  • IPO
  • (Cancelled)

  • Latest Deal Amount
  • $3M

Accelerated Pharma General Information

Description

Operator of a biotech pharmaceutical company intended to develop cancer drugs. The company focuses on in-licensing late-stage drug programs for ovarian, colorectal, and small-cell lung cancer patients and uses a drug development strategy based on individualized targeting of patients using genomics, providing the healthcare industry with novel cancer treatments.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Primary Industry
Biotechnology
Other Industries
Drug Discovery
Corporate Office
  • 15 West 155, 81st Street
  • Burr Ridge, IL 60527
  • United States
+1 (847) 000-0000

Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Accelerated Pharma Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
4. IPO 22-Oct-2018 $3M 000.00 Cancelled Clinical Trials - General
3. IPO 23-Aug-2017 00.00 000.00 Cancelled Clinical Trials - General
2. Early Stage VC 04-May-2016 $250K $3.55M Completed Clinical Trials - General
1. Seed Round 18-Nov-2015 $3.3M $3.3M Completed Startup
To view Accelerated Pharma’s complete valuation and funding history, request access »

Accelerated Pharma Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last
Financing
Details
Operator of a biotech pharmaceutical company intended to develop cancer drugs. The company focuses on in-licensing late-
Biotechnology
Burr Ridge, IL
6 As of 2019
00.000
000.00 0000-00-00
00000000

000000

sectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore m
0000 000000000
New York, NY
00 As of 0000
00000
00000 0000-00-00
00000000000 00000

00 000

, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad
0000000000000
Durham, NC
000 As of 0000
00000
00000000 00000
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

Accelerated Pharma Competitors (25)

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Volastra Venture Capital-Backed New York, NY 00 00000 00000000000 00000
G1 Therapeutics Formerly VC-backed Durham, NC 000 00000 00000000 00000
Loxo Oncology Formerly VC-backed Stamford, CT 00 00000 000000&0 00000
EPIRUS Biopharmaceuticals Corporation Boston, MA 00 000.00 000000000000 000.00
Amgen Formerly PE-Backed Thousand Oaks, CA 00000 000.00 000000000 000.00
You’re viewing 5 of 25 competitors. Get the full list »

Accelerated Pharma Executive Team (6)

Name Title Board Seat Contact Info
Michael Fonstein Ph.D Co-Founder, President, Chief Executive Officer, Interim Chief Financial Officer & Board Member
Randy Saluck JD Chief Financial and Strategic Officer
Ekaterina Nikolaevskaya Chief Operating Officer & Board Member
Michael Kurman MD Chief Clinical Advisor
Dmitry Prudnikov MD Chief Medical Officer & Board Member
You’re viewing 5 of 6 executive team members. Get the full list »

Accelerated Pharma Board Members (7)

Name Representing Role Since
Dmitry Prudnikov MD Accelerated Pharma Chief Medical Officer & Board Member 000 0000
Ekaterina Nikolaevskaya Accelerated Pharma Chief Operating Officer & Board Member 000 0000
Michael Fonstein Ph.D Accelerated Pharma Co-Founder, President, Chief Executive Officer, Interim Chief Financial Officer & Board Member 000 0000
Michael Yomtov Accelerated Pharma Board Member 000 0000
Rick Stevens Self Board Member 000 0000
You’re viewing 5 of 7 board members. Get the full list »

Accelerated Pharma Signals

Growth Rate

0.80% Weekly
Growth
Weekly Growth 0.80%, 93rd %
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Twitter Followers

5.5k

Similarweb Unique Visitors

15.0K

Majestic Referring Domains

314

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Accelerated Pharma FAQs

  • When was Accelerated Pharma founded?

    Accelerated Pharma was founded in 2014.

  • Who is the founder of Accelerated Pharma?

    Teddy Scott Ph.D and Michael Fonstein Ph.D are the founders of Accelerated Pharma.

  • Who is the CEO of Accelerated Pharma?

    Michael Fonstein Ph.D is the CEO of Accelerated Pharma.

  • Where is Accelerated Pharma headquartered?

    Accelerated Pharma is headquartered in Burr Ridge, IL.

  • What is the size of Accelerated Pharma?

    Accelerated Pharma has 6 total employees.

  • What industry is Accelerated Pharma in?

    Accelerated Pharma’s primary industry is Biotechnology.

  • Is Accelerated Pharma a private or public company?

    Accelerated Pharma is a Private company.

  • What is the current valuation of Accelerated Pharma?

    The current valuation of Accelerated Pharma is 000.00.

  • What is Accelerated Pharma’s current revenue?

    The current revenue for Accelerated Pharma is 000000.

  • How much funding has Accelerated Pharma raised over time?

    Accelerated Pharma has raised $3.55M.

  • Who are Accelerated Pharma’s competitors?

    Volastra, G1 Therapeutics, Loxo Oncology, EPIRUS Biopharmaceuticals, and Amgen are some of the 25 competitors of Accelerated Pharma.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read blog »
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process »